This report aims to provide a comprehensive presentation of the global market for Immune Cell Therapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Cell Therapy Drugs. This report contains market size and forecasts of Immune Cell Therapy Drugs in global, including the following market information:
Global Immune Cell Therapy Drugs Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Immune Cell Therapy Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2032, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Monoclonal Antibodies Segment to Reach $ Million by 2032, with a % CAGR in next six years.
The global key manufacturers of Immune Cell Therapy Drugs include Aquila BioMedical, BPS Bioscience, Celentyx, Crown Bioscience, DiscoverX Corporation, Explicyte, Genscript Biotech Corporation, HD Biosciences and Horizon Discovery Group, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Immune Cell Therapy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immune Cell Therapy Drugs Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Immune Cell Therapy Drugs Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Immunomodulator
Other
Global Immune Cell Therapy Drugs Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Immune Cell Therapy Drugs Market Segment Percentages, by Application, 2022 (%)
Stomach Cancer
lung Cancer
Colorectal Cancer
Esophageal Cancer
Pancreatic Cancer
Other
Global Immune Cell Therapy Drugs Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Immune Cell Therapy Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immune Cell Therapy Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immune Cell Therapy Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Aquila BioMedical
BPS Bioscience
Celentyx
Crown Bioscience
DiscoverX Corporation
Explicyte
Genscript Biotech Corporation
HD Biosciences
Horizon Discovery Group
ImmunXperts
Molecular Imaging
Promega Corporation,Personalis
STC Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immune Cell Therapy Drugs, market overview.
Chapter 2: Global Immune Cell Therapy Drugs market size in revenue.
Chapter 3: Detailed analysis of Immune Cell Therapy Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immune Cell Therapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Immune Cell Therapy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immune Cell Therapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immune Cell Therapy Drugs Overall Market Size
2.1 Global Immune Cell Therapy Drugs Market Size: 2022 VS 2032
2.2 Global Immune Cell Therapy Drugs Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immune Cell Therapy Drugs Players in Global Market
3.2 Top Global Immune Cell Therapy Drugs Companies Ranked by Revenue
3.3 Global Immune Cell Therapy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Immune Cell Therapy Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immune Cell Therapy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immune Cell Therapy Drugs Players in Global Market
3.6.1 List of Global Tier 1 Immune Cell Therapy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Immune Cell Therapy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immune Cell Therapy Drugs Market Size Markets, 2022 & 2032
4.1.2 Monoclonal Antibodies
4.1.3 Immunomodulator
4.1.4 Other
4.2 By Type - Global Immune Cell Therapy Drugs Revenue & Forecasts
4.2.1 By Type - Global Immune Cell Therapy Drugs Revenue, 2018-2023
4.2.2 By Type - Global Immune Cell Therapy Drugs Revenue, 2024-2032
4.2.3 By Type - Global Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immune Cell Therapy Drugs Market Size, 2022 & 2032
5.1.2 Stomach Cancer
5.1.3 lung Cancer
5.1.4 Colorectal Cancer
5.1.5 Esophageal Cancer
5.1.6 Pancreatic Cancer
5.1.7 Other
5.2 By Application - Global Immune Cell Therapy Drugs Revenue & Forecasts
5.2.1 By Application - Global Immune Cell Therapy Drugs Revenue, 2018-2023
5.2.2 By Application - Global Immune Cell Therapy Drugs Revenue, 2024-2032
5.2.3 By Application - Global Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Immune Cell Therapy Drugs Market Size, 2022 & 2032
6.2 By Region - Global Immune Cell Therapy Drugs Revenue & Forecasts
6.2.1 By Region - Global Immune Cell Therapy Drugs Revenue, 2018-2023
6.2.2 By Region - Global Immune Cell Therapy Drugs Revenue, 2024-2032
6.2.3 By Region - Global Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Immune Cell Therapy Drugs Revenue, 2018-2032
6.3.2 US Immune Cell Therapy Drugs Market Size, 2018-2032
6.3.3 Canada Immune Cell Therapy Drugs Market Size, 2018-2032
6.3.4 Mexico Immune Cell Therapy Drugs Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Immune Cell Therapy Drugs Revenue, 2018-2032
6.4.2 Germany Immune Cell Therapy Drugs Market Size, 2018-2032
6.4.3 France Immune Cell Therapy Drugs Market Size, 2018-2032
6.4.4 U.K. Immune Cell Therapy Drugs Market Size, 2018-2032
6.4.5 Italy Immune Cell Therapy Drugs Market Size, 2018-2032
6.4.6 Russia Immune Cell Therapy Drugs Market Size, 2018-2032
6.4.7 Nordic Countries Immune Cell Therapy Drugs Market Size, 2018-2032
6.4.8 Benelux Immune Cell Therapy Drugs Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Immune Cell Therapy Drugs Revenue, 2018-2032
6.5.2 China Immune Cell Therapy Drugs Market Size, 2018-2032
6.5.3 Japan Immune Cell Therapy Drugs Market Size, 2018-2032
6.5.4 South Korea Immune Cell Therapy Drugs Market Size, 2018-2032
6.5.5 Southeast Asia Immune Cell Therapy Drugs Market Size, 2018-2032
6.5.6 India Immune Cell Therapy Drugs Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Immune Cell Therapy Drugs Revenue, 2018-2032
6.6.2 Brazil Immune Cell Therapy Drugs Market Size, 2018-2032
6.6.3 Argentina Immune Cell Therapy Drugs Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immune Cell Therapy Drugs Revenue, 2018-2032
6.7.2 Turkey Immune Cell Therapy Drugs Market Size, 2018-2032
6.7.3 Israel Immune Cell Therapy Drugs Market Size, 2018-2032
6.7.4 Saudi Arabia Immune Cell Therapy Drugs Market Size, 2018-2032
6.7.5 UAE Immune Cell Therapy Drugs Market Size, 2018-2032
7 Immune Cell Therapy Drugs Companies Profiles
7.1 Aquila BioMedical
7.1.1 Aquila BioMedical Company Summary
7.1.2 Aquila BioMedical Business Overview
7.1.3 Aquila BioMedical Immune Cell Therapy Drugs Major Product Offerings
7.1.4 Aquila BioMedical Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.1.5 Aquila BioMedical Key News & Latest Developments
7.2 BPS Bioscience
7.2.1 BPS Bioscience Company Summary
7.2.2 BPS Bioscience Business Overview
7.2.3 BPS Bioscience Immune Cell Therapy Drugs Major Product Offerings
7.2.4 BPS Bioscience Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.2.5 BPS Bioscience Key News & Latest Developments
7.3 Celentyx
7.3.1 Celentyx Company Summary
7.3.2 Celentyx Business Overview
7.3.3 Celentyx Immune Cell Therapy Drugs Major Product Offerings
7.3.4 Celentyx Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.3.5 Celentyx Key News & Latest Developments
7.4 Crown Bioscience
7.4.1 Crown Bioscience Company Summary
7.4.2 Crown Bioscience Business Overview
7.4.3 Crown Bioscience Immune Cell Therapy Drugs Major Product Offerings
7.4.4 Crown Bioscience Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.4.5 Crown Bioscience Key News & Latest Developments
7.5 DiscoverX Corporation
7.5.1 DiscoverX Corporation Company Summary
7.5.2 DiscoverX Corporation Business Overview
7.5.3 DiscoverX Corporation Immune Cell Therapy Drugs Major Product Offerings
7.5.4 DiscoverX Corporation Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.5.5 DiscoverX Corporation Key News & Latest Developments
7.6 Explicyte
7.6.1 Explicyte Company Summary
7.6.2 Explicyte Business Overview
7.6.3 Explicyte Immune Cell Therapy Drugs Major Product Offerings
7.6.4 Explicyte Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.6.5 Explicyte Key News & Latest Developments
7.7 Genscript Biotech Corporation
7.7.1 Genscript Biotech Corporation Company Summary
7.7.2 Genscript Biotech Corporation Business Overview
7.7.3 Genscript Biotech Corporation Immune Cell Therapy Drugs Major Product Offerings
7.7.4 Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.7.5 Genscript Biotech Corporation Key News & Latest Developments
7.8 HD Biosciences
7.8.1 HD Biosciences Company Summary
7.8.2 HD Biosciences Business Overview
7.8.3 HD Biosciences Immune Cell Therapy Drugs Major Product Offerings
7.8.4 HD Biosciences Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.8.5 HD Biosciences Key News & Latest Developments
7.9 Horizon Discovery Group
7.9.1 Horizon Discovery Group Company Summary
7.9.2 Horizon Discovery Group Business Overview
7.9.3 Horizon Discovery Group Immune Cell Therapy Drugs Major Product Offerings
7.9.4 Horizon Discovery Group Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.9.5 Horizon Discovery Group Key News & Latest Developments
7.10 ImmunXperts
7.10.1 ImmunXperts Company Summary
7.10.2 ImmunXperts Business Overview
7.10.3 ImmunXperts Immune Cell Therapy Drugs Major Product Offerings
7.10.4 ImmunXperts Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.10.5 ImmunXperts Key News & Latest Developments
7.11 Molecular Imaging
7.11.1 Molecular Imaging Company Summary
7.11.2 Molecular Imaging Business Overview
7.11.3 Molecular Imaging Immune Cell Therapy Drugs Major Product Offerings
7.11.4 Molecular Imaging Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.11.5 Molecular Imaging Key News & Latest Developments
7.12 Promega Corporation,Personalis
7.12.1 Promega Corporation,Personalis Company Summary
7.12.2 Promega Corporation,Personalis Business Overview
7.12.3 Promega Corporation,Personalis Immune Cell Therapy Drugs Major Product Offerings
7.12.4 Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.12.5 Promega Corporation,Personalis Key News & Latest Developments
7.13 STC Biologics
7.13.1 STC Biologics Company Summary
7.13.2 STC Biologics Business Overview
7.13.3 STC Biologics Immune Cell Therapy Drugs Major Product Offerings
7.13.4 STC Biologics Immune Cell Therapy Drugs Revenue in Global Market (2018-2023)
7.13.5 STC Biologics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Immune Cell Therapy Drugs Market Opportunities & Trends in Global Market
Table 2. Immune Cell Therapy Drugs Market Drivers in Global Market
Table 3. Immune Cell Therapy Drugs Market Restraints in Global Market
Table 4. Key Players of Immune Cell Therapy Drugs in Global Market
Table 5. Top Immune Cell Therapy Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Immune Cell Therapy Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Immune Cell Therapy Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Immune Cell Therapy Drugs Product Type
Table 9. List of Global Tier 1 Immune Cell Therapy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immune Cell Therapy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Immune Cell Therapy Drugs Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Immune Cell Therapy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Immune Cell Therapy Drugs Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Immune Cell Therapy Drugs Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Immune Cell Therapy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Immune Cell Therapy Drugs Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Immune Cell Therapy Drugs Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Immune Cell Therapy Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Immune Cell Therapy Drugs Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Immune Cell Therapy Drugs Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Immune Cell Therapy Drugs Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Immune Cell Therapy Drugs Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Immune Cell Therapy Drugs Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Immune Cell Therapy Drugs Revenue, (US$, Mn), 2024-2032
Table 30. Aquila BioMedical Company Summary
Table 31. Aquila BioMedical Immune Cell Therapy Drugs Product Offerings
Table 32. Aquila BioMedical Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Aquila BioMedical Key News & Latest Developments
Table 34. BPS Bioscience Company Summary
Table 35. BPS Bioscience Immune Cell Therapy Drugs Product Offerings
Table 36. BPS Bioscience Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. BPS Bioscience Key News & Latest Developments
Table 38. Celentyx Company Summary
Table 39. Celentyx Immune Cell Therapy Drugs Product Offerings
Table 40. Celentyx Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Celentyx Key News & Latest Developments
Table 42. Crown Bioscience Company Summary
Table 43. Crown Bioscience Immune Cell Therapy Drugs Product Offerings
Table 44. Crown Bioscience Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Crown Bioscience Key News & Latest Developments
Table 46. DiscoverX Corporation Company Summary
Table 47. DiscoverX Corporation Immune Cell Therapy Drugs Product Offerings
Table 48. DiscoverX Corporation Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. DiscoverX Corporation Key News & Latest Developments
Table 50. Explicyte Company Summary
Table 51. Explicyte Immune Cell Therapy Drugs Product Offerings
Table 52. Explicyte Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Explicyte Key News & Latest Developments
Table 54. Genscript Biotech Corporation Company Summary
Table 55. Genscript Biotech Corporation Immune Cell Therapy Drugs Product Offerings
Table 56. Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Genscript Biotech Corporation Key News & Latest Developments
Table 58. HD Biosciences Company Summary
Table 59. HD Biosciences Immune Cell Therapy Drugs Product Offerings
Table 60. HD Biosciences Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. HD Biosciences Key News & Latest Developments
Table 62. Horizon Discovery Group Company Summary
Table 63. Horizon Discovery Group Immune Cell Therapy Drugs Product Offerings
Table 64. Horizon Discovery Group Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Horizon Discovery Group Key News & Latest Developments
Table 66. ImmunXperts Company Summary
Table 67. ImmunXperts Immune Cell Therapy Drugs Product Offerings
Table 68. ImmunXperts Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. ImmunXperts Key News & Latest Developments
Table 70. Molecular Imaging Company Summary
Table 71. Molecular Imaging Immune Cell Therapy Drugs Product Offerings
Table 72. Molecular Imaging Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Molecular Imaging Key News & Latest Developments
Table 74. Promega Corporation,Personalis Company Summary
Table 75. Promega Corporation,Personalis Immune Cell Therapy Drugs Product Offerings
Table 76. Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. Promega Corporation,Personalis Key News & Latest Developments
Table 78. STC Biologics Company Summary
Table 79. STC Biologics Immune Cell Therapy Drugs Product Offerings
Table 80. STC Biologics Immune Cell Therapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. STC Biologics Key News & Latest Developments
List of Figures
Figure 1. Immune Cell Therapy Drugs Segment by Type in 2022
Figure 2. Immune Cell Therapy Drugs Segment by Application in 2022
Figure 3. Global Immune Cell Therapy Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immune Cell Therapy Drugs Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Immune Cell Therapy Drugs Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immune Cell Therapy Drugs Revenue in 2022
Figure 8. By Type - Global Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
Figure 9. By Application - Global Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
Figure 10. By Type - Global Immune Cell Therapy Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
Figure 12. By Application - Global Immune Cell Therapy Drugs Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
Figure 14. By Region - Global Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
Figure 15. By Country - North America Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
Figure 16. US Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
Figure 20. Germany Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 21. France Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
Figure 28. China Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 32. India Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
Figure 34. Brazil Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Immune Cell Therapy Drugs Revenue Market Share, 2018-2032
Figure 37. Turkey Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Immune Cell Therapy Drugs Revenue, (US$, Mn), 2018-2032
Figure 41. Aquila BioMedical Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. BPS Bioscience Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celentyx Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Crown Bioscience Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. DiscoverX Corporation Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Explicyte Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Genscript Biotech Corporation Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. HD Biosciences Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Horizon Discovery Group Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. ImmunXperts Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Molecular Imaging Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Promega Corporation,Personalis Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. STC Biologics Immune Cell Therapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
